America Great Health (AAGH)

America Great Health is a U.S.-based biotechnology company whose common stock is listed on OTC Markets under the symbol AAGH. The company focuses on research and development in protein and peptide small-molecule drugs, while also working on the manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy products, regenerative medicine, and nutritional dietary supplements. It was previously known as Crown Marketing and adopted the America Great Health name in March 2017. The company is based in Alhambra, California.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Altman Z-Score Free Cash Flow / Net Income
OTC-AAGH
$0.00020
-33.3% Downside
Overvalued
Not available
Not available
Fair
0.0%
October 13, 2026
6.6x
11.6x
6.346 M
8.497 M
51.4%
-105.8
-55.2%
Valuation • Fair Value

America Great Health (OTC-AAGH) Fair Value by Valuation Model

Review the available estimates for America Great Health (OTC-AAGH), including DCF Fair Value, Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.00020

Estimated downside of 33.3% versus the current market price.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.00020

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0.00034

Classic Ben Graham valuation formula reference.

Comps Fair Value

$0.00020

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 5 available valuation references for America Great Health (OTC-AAGH) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for America Great Health (OTC-AAGH)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

363.332 K

Current operating scale indicator.

Revenue Forecast

470.092 K

Forward revenue estimate.

EBITDA

-370.106 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review America Great Health (OTC-AAGH) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for America Great Health (OTC-AAGH)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

24.36

Higher caution zone on this screen.

Altman Z-Score

-105.8

Lower score that deserves closer risk review.

FCF / Net Income

-55.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for America Great Health (OTC-AAGH). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for America Great Health (OTC-AAGH)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 13, 2026

Days to Earnings

25

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for America Great Health (OTC-AAGH), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for America Great Health (OTC-AAGH) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for America Great Health (OTC-AAGH) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for America Great Health (OTC-AAGH) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for America Great Health (OTC-AAGH) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for America Great Health (OTC-AAGH) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

America Great Health (OTC-AAGH) Stock FAQ

Data-supported answers about America Great Health (OTC-AAGH), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.00020
Estimated downside 33.3%
Valuation Rating
Overvalued
Estimated downside of 33.3%
Financial Health
Fair
Current financial-health read

The current fair value estimate for America Great Health (OTC-AAGH) is $0.00020. This implies an estimated downside of 33.3% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 33.3% versus the current market price.

The current financial health read for America Great Health (OTC-AAGH) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for America Great Health (OTC-AAGH) is October 13, 2026.

The latest available data indicates no current dividend yield for America Great Health (OTC-AAGH).

The current P/E ratio listed for America Great Health (OTC-AAGH) is 6.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for America Great Health is 6.346 M.

The current enterprise value listed for America Great Health is 8.497 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for America Great Health is OTC-AAGH, and the stock is listed on OTC Markets.

America Great Health (OTC-AAGH) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for America Great Health is 51.4%, which helps investors evaluate the company’s financing structure and leverage profile.